PCM
BDSI

Potomac Capital Management’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Potomac Capital Management’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-31,200
Closed -$377K – 99
2014
Q2 		$377K Sell
31,200
-17,001
-35% -$161K 0.3% 58
2014
Q1 		$407K Sell
48,201
-13,100
-21% -$106K 0.35% 51
2013
Q4 		$361K Buy
+61,301
New +$316K 0.31% 50

Other funds holding BDSI

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.51B AUM 37.25% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Potomac Capital Management's BDSI Position: Q3 2014 in Review

Potomac Capital Management sold out of BioDelivery Sciences International, Inc. (BDSI) in Q3 2014, closing a stake of 31,200 shares — an estimated $377K sold.

Potomac Capital Management first reported a position in BDSI in Q4 2013 and held it in 3 quarters. The position peaked at $407K in Q1 2014. 116 funds tracked by Wall St. Rank hold BDSI as of Q3 2014.

  • Potomac Capital Management reported no remaining BioDelivery Sciences International, Inc. position as of Q3 2014 after selling out during the quarter.
  • Potomac Capital Management sold 31,200 BioDelivery Sciences International, Inc. shares in Q3 2014, an estimated $377K.
  • Potomac Capital Management first reported a position in BioDelivery Sciences International, Inc. in Q4 2013 and held it in 3 quarters.
  • Potomac Capital Management's BioDelivery Sciences International, Inc. position peaked at $407K in Q1 2014.
  • 116 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q3 2014.

Based on Potomac Capital Management's 13F filing for Q3 2014, filed 23 Oct 2014.